Study of Individuals With Parkinson's Symptoms But in Whom There is Diagnostic Uncertainty

Completed · Phase 2

Conditions studied: Parkinsonian Syndrome

In brief

The overall goal of this study is to evaluate the use of dopamine transporter (DAT) imaging as a diagnostic tool in subjects with early parkinsonian symptoms, in whom Parkinson's disease (PD) or parkinsonian syndrome (PS) is suspected, but the diagnosis remains unclear from a clinical standpoint.

Key facts

Study ID

NCT00129675

Run by

Institute for Neurodegenerative Disorders

People needed

169

Starts

2003-02-01

Expected to finish

2009-05-01

Last updated by the study team

2014-07-16

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age >21
• Any parkinsonian or extrapyramidal symptoms
• Parkinsonian symptoms for < 2 years duration.
• No significant abnormalities on screening laboratory studies including: CBC, Chem-20 and urinalysis.
• Willingness to comply with study protocol.

You may not qualify if…

• Pregnancy
• Significant medical disease including abnormalities on screening biochemical or hematological labs or abnormal electrocardiogram (ECG).

Where it is running

• Institute for Neurodegenerative Disorders — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.